TELCON RF PHARMACEUTICAL. Inc.

Toward S means a higher total-score band; toward F, a lower band. Badges are distinguished by ink intensity and shape (fill, outline, dashed) — never by hue.

Maegim maps a total score — built from sector-relative percentile scoring — onto fixed, predefined thresholds to assign one of six bands, S to F. This stock is scored by the same formula as all 2,523 graded stocks and is currently in band B with a total score of 57.6 points.

How grades are computed →What grades do and don’t mean →What the grade does not reflect →

Position within sector

Mechanically selected indicators in the top or bottom 30% of sector percentiles · among 250 stocks in Pharma & Biotech

Upper percentile

Top 0.6% in sector — P/B (price-to-book)Price attractiveness →Top 1.6% in sector — Operating income change (YoY)Growth momentum →Top 13.7% in sector — Operating income change (3Y)Growth momentum →

Lower percentile

Bottom 6.3% in sector — P/E (price-to-earnings)Price attractiveness →

1-year closing price

Low ₩1,841High ₩15,484

Latest close

Price change by period

0.20%

2.30%

26.10%

85.60%

Adjusted for 1 price-basis change(s) such as stock splits or reverse splits during the period.

As of the Sep 2, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

Financial strength

48.0/100

How much debt does it carry relative to equity?

44.0%

Sector median 51.6%

Sector low

highTop 41.1% in sector

Can it cover what's due within a year?

124.8%

Sector median 191.7%

Sector low

highBottom 33.4% in sector

How much of revenue becomes profit?

1.7%

Sector median -2.4%

Sector low

highTop 43.2% in sector

How much did it earn on its own capital?

-10.6%

Sector median -4.5%

Sector low

highBottom 42.7% in sector

Source filing: annual report (consolidated) — view original ↗

Growth momentum

83.7/100

How much did revenue grow in a year?

14.0%

Sector median 6.4%

Sector low

highTop 31.6% in sector

Has it grown steadily over three years?

15.8%

Sector median 4.9%

Sector low

highTop 18.4% in sector

Did core profits grow in a year?

1118.6%

Sector median 3.6%

Sector low

highTop 1.6% in sector

Are core profits higher than three years ago?

117.7%

Sector median 3.5%

Sector low

highTop 13.7% in sector

Financial trend

Revenue

Growth & margin

Revenue growth Operating margin

Year over year — alongside the sector median

This stock Sector median

A factual chart of confirmed annual results from annual reports — the same source as the grading indicators. Not a buy or sell signal.

Source filing: annual report (consolidated) — view original ↗

Price attractiveness

52.9/100

Is the price expensive relative to earnings?

Loss-making (P/E not computable)

Sector median P/E of profitable peers 16.3x · 58% loss-making

Sector low

highBottom 6.3% in sector

Is the price expensive relative to book value?

0.20x

Sector median 1.61x

Sector low

highTop 0.6% in sector

Valuation uses the Sep 2, 2026 close and market cap

Shareholder Return

Single-indicator axis37.5/100

Does the company actually pay dividends?

0.0%

Sector median 0.0%

Sector low

highBottom 37.5% in sector

Dividends & treasury shares

Treasury shares (FY2025): 9,548 shares (0.0% of shares issued)

Source: annual report (DART) — dividend allocation & total shares

Source filing: annual report (consolidated) — view original ↗

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 2, 2026

Of 9 items: 7 met · 2 not met · 0 not computable

Not metMetNot computable

Positive net income

Whether net income (attributable to owners where available) is above zero.

Not met

-₩11.5B

Positive operating cash flow

Whether cash flow from operations is above zero.

Met

₩1.7B

Return on assets up

Whether net income over beginning total assets rose from the prior year.

Met

-18.7% → -7.5%

Operating cash flow exceeds net income

Whether operating cash flow is greater than net income.

Met

₩1.7B vs -₩11.5B

Liabilities-to-assets ratio down

Whether total liabilities as a share of total assets fell from the prior year.

Met

45.9% → 30.5%

Current ratio up

Whether current assets over current liabilities rose from the prior year.

Met

37.3% → 124.8%

Shares outstanding not increased

Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.

Not met

12,025,023 → 68,523,533

Operating margin up

Whether operating income over revenue rose from the prior year.

Met

-0.2% → 1.7%

Asset turnover up

Whether revenue over beginning total assets rose from the prior year.

Met

0.27x → 0.28x

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (consolidated) — view original ↗

Grade change history

Jul 23, 2026B

Methodology version change (v2.0 applied)

Jul 15, 2026BVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Disclosure & financial badges

Factual records determined from public filings and periodic reports by fixed rules — not buy/sell signals.

Negative-evidence group (dilution, loss, dispute)Mixed interpretationPositive-evidence group (shareholder return)Dots classify the disclosure type by the direction of research evidence — not an assessment or investment judgment about this company.

Disclosure event history

Large paid-in capital increase resolved

Disclosed a paid-in capital increase (제3자배정증자) issuing 2,329,916 new shares, equal to 32.6% of shares outstanding before the increase (filed 2026-07-06). View filing ↗

Private CB/BW issuance resolutions (past 36 months)

3 private-placement convertible bond (CB) / bond-with-warrants (BW) issuance resolutions were disclosed in the past 36 months (latest filing 2025-04-21). View filing ↗

CB with conversion-price adjustment clause (past 36 months)

3 convertible bond (CB) issuance resolutions including a downward conversion-price adjustment (refixing) clause were disclosed in the past 36 months (latest filing 2025-04-21). View filing ↗

Determined as of 2026-09-02

Recent filings for this stock

Last 120 days · monitored filing types only

Periodic report filedAug 14, 2026Source ↗

Paid-in capital increaseJul 6, 2026Source ↗

Periodic report filedMay 15, 2026Source ↗

View in the filings calendar →